Cargando…
Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia
Beta-lactam antibiotics commonly cause immune thrombocytopenia. Cross-reactivity in patients with drug-induced immune thrombocytopenia has rarely been reported. In this study, we describe the case of a 79-year-old man who developed thrombocytopenia after receiving piperacillin–tazobactam for an acut...
Autores principales: | He, Xiaoyan, Huang, Wanting, Wan, Xiong, Li, Xiaoya, Chang, Qiuhong, Ding, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052494/ https://www.ncbi.nlm.nih.gov/pubmed/36967671 http://dx.doi.org/10.1177/03000605231162434 |
Ejemplares similares
-
Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
por: Wang, Xueting, et al.
Publicado: (2023) -
Comparison of antibiotic-associated diarrhea caused by
cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery
patients
por: Chen, Yue, et al.
Publicado: (2021) -
The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia
por: Lai, Chih-Cheng, et al.
Publicado: (2023) -
Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Chen, Chia-Hung, et al.
Publicado: (2021) -
Cefoperazone sodium/sulbactam sodium vs piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients
por: Wang, Xiao-Xia, et al.
Publicado: (2021)